Deciphera Pharmaceuticals, a biopharmaceutical company dedicated to discovering and developing innovative medicines to improve the lives of cancer patients, has announced the pricing of a … Read more
At the American Association for Cancer Research (AACR) special conference on acute myeloid leukemia and myelodysplastic syndrome, taking place January 23-25, 2023 in Austin, TX, … Read more
ANGLE plc, a revolutionary liquid biopsy company, is pleased to welcome Dr. Joseph (Joe) Eid to its board of Non-Executive Directors. Dr. Eid’s appointment will … Read more
Annogen is working to create multiple CNS-cell specific promoters that can be used in VectorY programs. This innovative approach will help to further advance the … Read more
Prenetics Global Limited, a leader in the fields of genomic and diagnostic testing, is proud to announce the appointment of Dr. Bayju Thakar as CEO … Read more
Scenic Biotech, a leader in the groundbreaking world of genetic modifier drugs, has announced the appointment of Kristof Van Emelen, PhD, as Vice President of … Read more
XNK Therapeutics AB has appointed Dr. Peter Hovstadius as its new Chief Medical Officer, effective immediately. He will join the company’s management team, while Dr. … Read more
Last week, NRx Pharmaceuticals, Inc., a clinical-stage central nervous system (CNS) biopharmaceutical company, had a productive meeting with the Food and Drug Administration (FDA), who … Read more
AVAIL SCIENTIFIC is thrilled to announce that it is taking an exciting step forward by entering into a letter of intent (LOI) to acquire Relai … Read more
Teva Pharmaceuticals Industries Ltd is proud to have its targets to reduce greenhouse gas (GHG) emissions approved by the Science Based Targets initiative (SBTi), demonstrating … Read more
Repare Therapeutics Inc., a cutting-edge clinical-stage precision oncology company, announced that it has received a research service payment of approximately $1.5 million (¥200 million) from … Read more
Normunity, Inc., a biotechnology company creating innovative precision anti-cancer immunotherapies, is thrilled to announce the appointment of Olga Granaturova, MBA, as Chief Operating Officer and … Read more
SurModics, Inc. announced that they have received a letter from the U.S. Food and Drug Administration (FDA) regarding their premarket approval (PMA) application for the … Read more
bluebird bio, Inc. announced the pricing of its public offering of 20,000,000 shares of common stock at a public offering price of $6.00 per share, … Read more
Kaneka Corporation is taking the initiative to expand its GMP manufacturing capacity for mRNA with a capital investment of 2 billion JPY. By the end … Read more
Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided a comprehensive corporate update from its headquarters in Geneva, … Read more
KDDI Corporation, based in Tokyo, is proud to announce that its ambitious greenhouse gas (GHG) emissions reduction targets have been validated and approved by the … Read more
Junshi Biosciences announced Wednesday that their Phase III Neotorch trial of the anti-PD-1 monoclonal antibody, toripalimab, had achieved its primary endpoint in non-small cell lung … Read more
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, is proud to announce that its partner SK bioscience has received … Read more
BeiGene is making history by expanding access to life-changing drugs in China! For the first time ever, drugs are being added to the nation’s Reimbursement … Read more
BriaCell Therapeutics Corporation is delighted to announce that its lead clinical candidate, Bria-IMT™, in combination with a checkpoint inhibitor, has been met with agreement and … Read more
The Lupus Research Alliance (LRA) is delighted to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to head up Lupus Therapeutics, … Read more
Cryoablation technology is at the forefront of innovation, and we are proud to be a global leader in this field. Our success is evidenced by … Read more
SOFIE Biosciences, a renowned US-based manufacturer of radiopharmaceuticals, is proud to announce its support of Yantai LNC Biotechnology’s recently FDA-approved clinical study – with the … Read more
Ceruvia Lifesciences made history today, dosing the first participant in their Phase 1 clinical trial of NYPRG-101 (2-bromo-d-lysergic acid diethylamide). The pioneering trial marks an … Read more
Researchers have been able to pinpoint the lowest effective dose of a medication or therapy, thanks to a successful study. This breakthrough provides an invaluable … Read more
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK, OTC: PYNKF, FSE: 4PC) – a commercial-stage medical technology company – is proud to announce its new Board … Read more
Exploring the role of gamma-delta T cells in oncological settings is an exciting area of research with potentially groundbreaking implications. By devoting our attention to … Read more
Aclarion, Inc., a healthcare technology company utilizing biomarkers and proprietary augmented intelligence algorithms to help physicians determine the source of chronic low back pain, is … Read more
A recent study published in the Journal of Clinical Medicine has validated the efficacy of Biobeat’s wrist monitor for advanced noninvasive hemodynamic monitoring in heart … Read more
Agilis RoboticsTM (Agilis) is revolutionizing endoscopic surgery with its groundbreaking robotic instruments. Co-founder Dr. Jason Y.K. Chan recently completed a successful live animal test on … Read more
OncoK9’s potential for detecting cancer recurrence and residual disease after surgery or treatment is impressive, as evidenced by the results of PetDx’s analysis. With its … Read more
Ascletis Pharma Inc. (HKEX: 1672), a China-based biopharmaceutical company, announced today that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply … Read more
Scientists from the University of Texas Southwestern Medical Center have made a remarkable breakthrough: using base editing technology, they have managed to repair damaged heart … Read more
We are delighted to report that our clinical trial has produced positive results on both primary and secondary endpoints, allowing us to identify a dose … Read more
World’s First Approved Biosimilar to Actemra® Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company based in Guangzhou, China, has just made a major breakthrough in medical … Read more
CARsgen Therapeutics Holdings Limited (2171.HK) and Huadong Medicine (Hangzhou) Co., Ltd., a subsidiary of Huadong Medicine Co., Ltd. (SZ: 000963), have joined forces in an … Read more
Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) is delighted to announce a placement of KZA shares to institutional and sophisticated investors in Australia, at a … Read more
Predictive Oncology Inc. (NASDAQ: POAI) is thrilled to announce the appointment of Robert F. Murphy, Ph.D. to its Scientific Advisory Board. With his expertise and … Read more
Cytovance Biologics, a premier biopharmaceutical CDMO of mammalian and microbial biologics, is proud to announce the appointment of Ping Zhang as its new Chief Executive … Read more
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a pioneering biotechnology company dedicated to improving lives by developing precision-engineered medicines to silence diseases, provided … Read more
Introducing CliniPrime Fresh Leukopak, the revolutionary technology that will revolutionize clinical trials and advance the commercialization of advanced therapies. With this launch, we are revolutionizing … Read more
BIOLASE, Inc., the leading global provider of dental lasers, was recently honored with the prestigious Top Workplaces 2022 award from the Orange County Register. The … Read more
Extendicare Inc. (TSX: EXE) declared a cash dividend of C$0.04 per Common Share for the month of January 2023, to be paid out on February … Read more
BioArctic AB’s partner, Eisai, has recently submitted a marketing authorization application for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody for the treatment of mild … Read more
EDP Biotech Corporation is thrilled to welcome Sam Libby as their new Head of Mergers & Acquisitions and Corporate Development. With Libby’s expertise on board, … Read more
VolitionRx Limited (NYSE AMERICAN: VNRX) is proud to announce the launch of its revolutionary Nu.Q® Vet Cancer Test, now available in the United States through … Read more
ALiA BioTech’s rapid diagnostic platform is capable of providing up to 30 accurate results from a single drop of body fluid – whether it be … Read more
Eisai Co., Ltd. and Biogen Inc. have made a groundbreaking announcement today: they have jointly submitted a marketing authorization application for lecanemab, a revolutionary anti-amyloid … Read more
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197) has made a commitment to use innovative vaccines to save lives and improve public health across the world. Today, … Read more
Enrolling 72 healthy volunteers, we are excited to launch a multiple-dose escalation Phase I clinical trial in the first quarter of 2023. Be a part … Read more
Eli Lilly had an incredible year with the launch of their diabetes drug Mounjaro (tirzepatide). Now, the company is gearing up for an even bigger … Read more
As JP Morgan week kicked off in 2023, Alto Neuroscience was named number seven on BioSpace’s NextGen Bio 2023 list and brought with it positive … Read more
At the 41st J.P. Morgan Healthcare Conference in San Francisco, AbbVie’s CEO Rick Gonzalez talked about the company’s plans to adjust to the impending loss … Read more
Midatech Pharma PLC is delighted to announce that their Phase I study of MTX-110 in recurrent glioblastoma (NCT 05324501) will continue with a planned dose … Read more
IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a Gothenburg-based company developing pioneering treatments for Parkinson’s disease, has nominated a drug candidate from its P003 research … Read more
Pixium Vision has achieved a major milestone — the publication of two peer-reviewed studies showcasing the potential of the Next Generation PRIMA implant to restore … Read more
Biophytis SA (NasdaqCM: BPTS)(Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics to slow the degenerative processes of aging and … Read more
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company dedicated to the development of oral drug delivery systems, has released the top-line results of its … Read more
iNtRON Biotechnology is delighted to announce that their Tech Transfer process for SAL200, a revolutionary endolysin-based biologic, is entering its final stage! This out-licensing and … Read more
Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), a biotech business focused on the licensing and reselling of … Read more
MTD Group – a global leader in medical devices – is proud to announce that its affiliate Pikdare S.p.A. has just obtained FDA clearance for … Read more
S2 Genomics, Inc., a leader in single-cell genomics and cell biology applications, is thrilled to announce its new distribution agreement with Bonsailab. This agreement enables … Read more
Our total company net revenue is expected to skyrocket over the next two years! For Q4 of 2021, we forecast an impressive 61% y/y increase, … Read more
Zomedica Corp. (NYSE American:ZOM), a veterinary health company that provides point-of-care diagnostics and therapeutic products for companion animals, announced that CEO Larry Heaton will be … Read more
Apple has been found to be in violation of the Tariff Act of 1930, after a United States Administrative Law Judge in Washington, D.C. determined … Read more
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) granted inducement awards to four new employees under its 2020 Inducement Plan on January 10, 2023. Each employee was offered … Read more
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), has … Read more
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has made a major move in the fight against Alzheimer’s disease today, submitting a marketing authorization … Read more
Sequana Medical NV (Euronext Brussels: SEQUA), a leader in the treatment of fluid overload in liver disease, heart failure, and cancer, is cordially inviting all … Read more
Fiscal year 2022 was a banner year for Basilea Pharmaceutica Ltd, with significant revenue contributions from the commercial success of Cresemba and Zevtera and proceeds … Read more
Santhera Pharmaceuticals (SIX: SANN) is pleased to announce that, through a share exchange, it will receive the equivalent of CHF 5 million Idorsia shares. This … Read more
Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced a major milestone in its development as the first patient … Read more
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company dedicated to the development of IgM antibodies, today shared an update on its clinical development program … Read more
NovoCure Ltd. (NASDAQ: NVCR), a global oncology company dedicated to extending survival for those suffering from some of the most aggressive forms of cancer, announced … Read more
PacBio is thrilled to announce the launch of their PacBio Compatible Program, accompanied by positive Onso Beta feedback and preliminary fourth quarter 2022 revenue figures. … Read more
PerkinElmer Inc., a leading innovator driving a healthier world, will announce its fourth quarter and full year 2022 financial results on Tuesday, February 14th, 2023 … Read more
Rani Therapeutics Holdings, Inc. (Nasdaq: RANI) – a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs – today announced an exciting … Read more
SK Inc. is set to spark innovative ideas and identify new business opportunities with its global strategy and growth roadmap at an event attended by … Read more
Introducing a revolutionary new optofluidic system – a two-chip, single-cell device perfect for small to mid-sized biopharma and CDMOs/CROs. Now, you can have access to … Read more
TRex Bio, Inc., a biotechnology company decoding human tissue immune biology to create revolutionary therapeutics, has announced a multi-year research collaboration and exclusive worldwide license … Read more
CONMED Corporation (NYSE: CNMD) today announced that it will report its financial results for the fourth quarter of 2022 after market close on Thursday, February … Read more
Arrowhead Pharmaceuticals announced positive results from the Phase 3 clinical trial of fazirsiran for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Patients receiving fazirsiran experienced … Read more
Quanterix Corporation (NASDAQ: QTRX) is revolutionizing scientific discovery and breakthrough diagnostics through their ultrasensitive biomarker detection. Today, the company has announced the validation of a … Read more
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, recently granted inducement awards to two … Read more
Precision BioSciences, Inc. (Nasdaq: DTIL) is proud to announce its impressive accomplishments in 2022 and outline its plans for 2023. The clinical-stage gene editing company … Read more
We are proud to report that our total revenue for 2022 is expected to exceed the top end of the guided range of $132–137 million. … Read more
We are excited to announce five pivotal trials in the field of rare hematological diseases, with strong clinical data to support them. Our goal is … Read more
Genexine, a Korean biopharmaceutical company dedicated to discovering and developing treatments for unmet medical needs, has released new results from their Phase 2 clinical study … Read more
PBS Biotech, a leader in single-use bioreactors and process development services, recently announced the completion of a $22 million financing round led by Avego Management, … Read more
BioArctic AB’s partner Eisai announced today that they have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) in … Read more
ChromaDex Inc. (NASDAQ: CDXC), a leading bioscience company devoted to healthy aging, is delighted to announce the appointment of Brianna Gerber as its new Chief … Read more
IONIQ Sciences, Inc., formerly known as ProLung, Inc., is excited to announce its attendance at Biotech Showcase™, the globally renowned investor conference for innovators. CEO … Read more
We are thrilled to be advancing our small molecule therapeutic candidates, which have promising clinical and preclinical data suggesting neuroprotective, neurotrophic, procognitive, and disease-modifying effects. … Read more
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, is … Read more
Kira Pharmaceuticals, a biotechnology leader in cutting-edge complement therapies to treat immune-mediated diseases, is proud to announce that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, … Read more
Triumvira Immunologics, a clinical-stage company developing groundbreaking T cell therapies to fight solid tumors, today announced a clinical trial collaboration and supply agreement with Merck. … Read more
Looking for the biotech industry’s hottest spots? Look no further than BioSpace’s exclusive Hotbed Maps! Our vibrant, one-of-a-kind map highlights the nine regions to watch … Read more
Metagenomi is starting the new year off with a bang, having just secured an additional $100 million in a Series B extension financing round announced … Read more
NovoCure Ltd., based in Switzerland, has just announced that its Phase III LUNAR trial has successfully met its primary endpoint in patients with non-small cell … Read more
As the FDA nears its decision on Biogen and Eisai’s lecanemab, a new potential death linked to the Alzheimer’s drug has been revealed in a … Read more
Galmed Pharmaceuticals’ synthetic small molecule candidate, aramchol, has proven to be a powerful tool in the fight against non-alcoholic steatohepatitis (NASH), following Phase III ARMOR … Read more
Emergent Health Corp. (OTC PINK:EMGE), a leading provider of innovative products in the Regenerative Health Space, has reported an impressive 100% quarter-over-quarter revenue increase for … Read more
Psilocybin-assisted psychotherapy appears to be a promising treatment approach for Binge Eating Disorder, with preliminary research showing encouraging results. By combining the power of psychedelic-assisted … Read more
Duality is thrilled to announce the granting of a license for its DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP … Read more
Ascentage Pharma (6855.HK), a pioneering biopharmaceutical company revolutionizing the way cancer, chronic hepatitis B (CHB), and age-related diseases are treated, is thrilled to announce that … Read more
YDS Pharmatech, Inc., a techbio startup revolutionizing drug design with its low-data-dependent AI solutions, is proud to present its latest innovations at Biotech Showcase™ 2023. … Read more
InnoCare Pharma (HKEX: 09969; SSE: 688428), a pioneering biopharmaceutical company dedicated to the treatment of cancer and autoimmune diseases, is pleased to announce that it … Read more
WuXi Biologics has just signed an exclusive license agreement with GSK that grants them access to preclinical bi-specific T cell engaging (TCE) antibodies, with the … Read more
JPMorgan week is proving to be a successful return to the pre-pandemic days, with executives flocking to San Francisco after two years of COVID-19-enforced absence. … Read more
Innovent Biologics, Inc. – a leading global biopharmaceutical company – has been granted Breakthrough Therapy Designation (BTD) by China’s National Medical Products Administration (NMPA) for … Read more
Virax Biolabs, a cutting-edge biotechnology firm dedicated to the prevention, detection, and diagnosis of viral diseases, has just announced the launch of its HPV test … Read more
The FOURIER trial recently revealed that Amgen’s injectable cholesterol therapeutic, Repatha (evolocumab), may lead to an increased risk of cardiovascular death. This finding was revealed … Read more
Pharnext SA (FR001400BV89:ALPHA), an innovative biopharmaceutical company that is developing groundbreaking treatments for neurodegenerative disorders with an urgent need for solutions, is delighted to welcome … Read more
Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company dedicated to advancing treatments for hard-to-treat hematologic diseases, has appointed Dr Monica Shaw as its new … Read more
We are thrilled to announce that we have secured exclusive global rights to a potentially best-in-class gene therapy for Spinal Muscular Atrophy from UMass Chan … Read more
Bioretec Ltd, a leader in bioresorbable orthopedic implants, have received confirmation from the FDA that their supplement for the market authorization request for the RemeOs™ … Read more
Sanofi proudly announced today that the Memorandum for Q4 2022, for modelling purposes, is now available for investors to access on the company’s website. This … Read more
Orano Med, a pioneering clinical stage radiopharmaceutical company, today announced a major breakthrough with the first patient being dosed in their Phase 1 trial of … Read more
Hemogenyx Pharmaceuticals plc (LSE:HEMO) is thrilled to report the successful accomplishment of its second Process Qualification (“PQ”) run of the end-to-end manufacturing process for its … Read more
Sedana Medical AB (publ) (SEDANA: FN Stockholm) is thrilled to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) … Read more
TherapeuticsMD, Inc. (NASDAQ: TXMD) has successfully completed the previously announced transaction with Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company. Through this agreement, TherapeuticsMD … Read more
Phase 3 Trials for a potential new treatment are set to begin enrollment in the second quarter of 2023, pending discussions with the FDA. Exciting … Read more
ResMed (NYSE: RMD, ASX: RMD) is pleased to announce that Mick Farrell, its chief executive officer, will take the stage at the 41st Annual J.P. … Read more
Blacksmith Medicines and Forge Therapeutics are joining forces to revolutionize the biopharma industry with a groundbreaking merger. Combining their chemistry platforms, the companies are dedicated … Read more
argenx, a global immunology company dedicated to transforming the lives of those living with severe autoimmune diseases, is proud to announce that its Chief Executive … Read more
Antengene Corporation Limited (SEHK: 6996.HK) is thrilled to announce that it will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January … Read more
Photocure ASA, The Bladder Cancer Company, is pleased to announce the publication of a groundbreaking study in Urologic Oncology this week. Entitled ‘Clinical and Economic … Read more
Masimo SpHb has been shown to measure hemoglobin levels with “clinically acceptable accuracy” – even at the lowest levels. This breakthrough technology offers reliable and … Read more
Minovia Therapeutics, a clinical-stage global biotechnology company, is thrilled to announce its attendance at the upcoming Biotech Showcase in San Francisco, CA on Tuesday, January … Read more
Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) held its Annual General Meeting of Shareholders in Vancouver, British Columbia on December 30, 2022, with … Read more
MedMira Inc. (TSXV:MIR) unveiled its financial results for the quarter ending October 31, 2022, revealing a period of strong growth and increased profitability. The Halifax-based … Read more
The submission to regulatory authorities is a crucial step towards obtaining marketing authorization for the use of a new treatment in the fight against unresectable … Read more
Building on the promising results of its monotherapeutic activity in a previous clinical trial, ONC-392 is now entering Phase 2 of a multicenter, open-label combination … Read more
Astex Pharmaceuticals, UK, is proud to congratulate its co-founder, President and CEO, Harren Jhoti, PhD, FRS, FMedSci, on being honoured with an Officer of the … Read more
“Two Years and Older: Negative COVID-19 Test Now Required for Air Travel to Canada!” In response to the surge of COVID-19 cases in the People’s … Read more
Experts have expressed their concerns that the loosening of China’s COVID-19 restrictions could lead to an increased risk of the virus mutating. William Schaffner, professor … Read more
Pfizer Inc. (NYSE: PFE) announced today the positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) of its investigational gene therapy, fidanacogene elaparvovec, for … Read more
Evofem Biosciences, Inc. (OTCQB: EVFM) has been granted an extension by the OTC Markets Group to submit its Quarterly Report on Form 10-Q for the … Read more
With extensive experience in the industry, a new director has been appointed to position the company for growth. This individual brings an impressive knowledge base … Read more
Everest Medicines (HKEX: 1952), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative medicines and vaccines, is proud to announce its new corporate strategy. … Read more
ABM Respiratory Care, a leading medical technology company, is excited to announce the U.S. Food and Drug Administration’s 510(k) clearance of its groundbreaking BiWaze® Clear … Read more
Néovacs has made a significant commitment to increase its funding for the upcoming pivotal Phase III clinical trial of PXT3003, a potential treatment for Charcot-Marie-Tooth … Read more
NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (“NuGen” or the “Company”) has successfully closed the first tranche of its non-brokered private placement, raising a total of $125,000 … Read more
NXC-201, a pioneering CAR-T therapy for multiple myeloma and AL amyloidosis, will have its latest clinical data unveiled at the upcoming Rotterdam event on February … Read more
Come join us in Rotterdam, Netherlands February 9-11, 2023 for the presentation of updated clinical data on NXC-201, a next-generation CAR-T treatment for multiple myeloma … Read more
The National Cancer Institute recently conducted a Phase 2 clinical trial to assess the efficacy of PDS0101 triple combination in treating HPV16-positive cancer patients who … Read more
Varex Imaging Corporation (Nasdaq: VREX) is thrilled to announce its participation in CJS Securities 23rd Annual New Ideas for the New Year virtual investor conferences, … Read more
CEL-SCI Corporation (NYSE American: CVM) recently announced its financial results for the fiscal year ended September 30, 2022, along with several noteworthy clinical and corporate … Read more
XENOVIEW is a groundbreaking hyperpolarized MRI contrast agent that is the first and only of its kind to receive FDA approval for both adolescents and … Read more
Alphatec Holdings, Inc. (Nasdaq: ATEC) is excited to announce its virtual participation in the 25th Annual Needham Growth Conference! Join us on January 12, 2023 … Read more
Stryker (NYSE: SYK) has announced an upcoming conference call to review the company’s performance for the quarter ending December 31, 2022, and provide an operational … Read more
Akoya Biosciences, Inc. (Nasdaq: AKYA) – The Spatial Biology Company® – is thrilled to announce that it will be taking part in the 41st Annual … Read more
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) is proud to announce that their Phase 3 trial (NCT05341609) comparing the efficacy and … Read more
Qilu Pharmaceutical is making waves in the medical industry with its innovative bifunctional antibody, QL1706, by presenting the latest progress of its clinical studies at … Read more
Skanska and HGR General Contractors have teamed up to construct a state-of-the-art medical education building for The University of Texas at Tyler. The contract, worth … Read more
Skanska has secured a USD 95M (SEK 960M) contract to expand the Christus Santa Rosa Hospital-Westover Hills Hospital in San Antonio, Texas, USA. The project … Read more
Guardant Health, Inc. (Nasdaq: GH), a cutting-edge precision oncology company, is pleased to announce its attendance at the upcoming 41st Annual J.P. Morgan Healthcare Conference. … Read more
RxSight Inc., a leading ophthalmic medical device company committed to restoring the vision of cataract surgery patients, is thrilled to announce its participation in the … Read more
Cardio Diagnostics Holdings Inc (Nasdaq: CDIO) and Houston Concierge Medicine have joined forces to provide a revolutionary new test for coronary heart disease. Cardio Diagnostics’ … Read more
Harm Reduction Therapeutics (HRT), Inc., the 501(c)(3) nonprofit pharmaceutical company working to prevent opioid overdose deaths, has made an exciting breakthrough: the FDA has accepted … Read more